Unknown

Dataset Information

0

Bioengineered particles expand myelin-specific regulatory T cells and reverse autoreactivity in a mouse model of multiple sclerosis.


ABSTRACT: Multiple sclerosis (MS) is an autoimmune disease characterized by autoreactive immune cells damaging myelinated nerves, impairing brain function. Treatments aim for tolerance induction to reeducate the immune system to recognize myelin as "self" rather than "foreign." As peripheral immune tolerance is primarily mediated by regulatory T cells (Tregs), we developed a therapy to support Treg expansion and activity in vivo. To target, engage, and activate myelin-specific Tregs, we designed a biodegradable microparticle (MP) loaded with rapamycin and functionalized with a biased interleukin-2 (IL-2) fusion protein and a major histocompatibility complex (MHC) class II loaded with a myelin peptide. These tolerogenic MPs (Tol-MPs) were validated in vitro and then evaluated in a mouse model of MS, experimental autoimmune encephalomyelitis (EAE). Tol-MPs promoted sustained disease reversal in 100% of mice and full recovery in 38% of mice with symptomatic EAE. Tol-MPs are a promising platform for treatment of autoimmune diseases.

SUBMITTER: Rhodes KR 

PROVIDER: S-EPMC10413683 | biostudies-literature | 2023 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Bioengineered particles expand myelin-specific regulatory T cells and reverse autoreactivity in a mouse model of multiple sclerosis.

Rhodes Kelly R KR   Tzeng Stephany Y SY   Iglesias Marcos M   Lee Dongwoo D   Storm Kaitlyn K   Neshat Sarah Y SY   VanDyke Derek D   Lowmaster Shirley M SM   Spangler Jamie B JB   Raimondi Giorgio G   Green Jordan J JJ  

Science advances 20230602 22


Multiple sclerosis (MS) is an autoimmune disease characterized by autoreactive immune cells damaging myelinated nerves, impairing brain function. Treatments aim for tolerance induction to reeducate the immune system to recognize myelin as "self" rather than "foreign." As peripheral immune tolerance is primarily mediated by regulatory T cells (T<sub>regs</sub>), we developed a therapy to support T<sub>reg</sub> expansion and activity in vivo. To target, engage, and activate myelin-specific T<sub>  ...[more]

Similar Datasets

| S-EPMC11417334 | biostudies-literature
| S-EPMC4693592 | biostudies-literature
| S-EPMC3250284 | biostudies-literature
| S-EPMC4061877 | biostudies-literature
| S-EPMC7513961 | biostudies-literature
| S-EPMC4693593 | biostudies-literature
| S-EPMC6037698 | biostudies-literature
| S-EPMC4798764 | biostudies-literature
| S-EPMC8374972 | biostudies-literature
| S-EPMC4117317 | biostudies-other